------------------------------ ---------------------
CUSIP NO. 543162101 SCHEDULE 13D PAGE 2 OF 13 PAGES
------------------------------ ---------------------
--------------------------------------------------------------------------------
1 NAME OF REPORTING PERSON
ADVISORY RESEARCH, INC.
--------------------------------------------------------------------------------
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (a) [X]
(b) [ ]
--------------------------------------------------------------------------------
3 SEC USE ONLY
--------------------------------------------------------------------------------
4 SOURCE OF FUNDS*
OO
--------------------------------------------------------------------------------
5 CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT
TO ITEMS 2(d) or 2(e) [ ]
--------------------------------------------------------------------------------
6 CITIZENSHIP OR PLACE OF ORGANIZATION
DELAWARE
--------------------------------------------------------------------------------
7 SOLE VOTING POWER
-0-
----------------------------------------------------------
NUMBER OF 8 SHARED VOTING POWER
SHARES
BENEFICIALLY 3,295,893
OWNED BY ----------------------------------------------------------
EACH 9 SOLE DISPOSITIVE POWER
REPORTING
PERSON WITH -0-
----------------------------------------------------------
10 SHARED DISPOSITIVE POWER
3,295,893
--------------------------------------------------------------------------------
11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH PERSON
3,295,893
--------------------------------------------------------------------------------
12 CHECK IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES
CERTAIN SHARES*
[ ]
--------------------------------------------------------------------------------
13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
9.2% (1)
--------------------------------------------------------------------------------
14 TYPE OF REPORTING PERSON*
IA
--------------------------------------------------------------------------------
* SEE INSTRUCTIONS
(1) Based on 36,007,597 outstanding shares of the common stock of the Company,
as reported in the Company's Schedule 14D9, filed with the Securities and
Exchange Commission on August 18, 2008.
------------------------------ ---------------------
CUSIP NO. 543162101 SCHEDULE 13D PAGE 3 OF 13 PAGES
------------------------------ ---------------------
--------------------------------------------------------------------------------
1 NAME OF REPORTING PERSON
ADVISORY RESEARCH SMALL CAP EQUITY FUND, L.P.
--------------------------------------------------------------------------------
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (a) [X]
(b) [ ]
--------------------------------------------------------------------------------
3 SEC USE ONLY
--------------------------------------------------------------------------------
4 SOURCE OF FUNDS*
OO
--------------------------------------------------------------------------------
5 CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT
TO ITEMS 2(d) or 2(e) [ ]
--------------------------------------------------------------------------------
6 CITIZENSHIP OR PLACE OF ORGANIZATION
ILLINOIS
--------------------------------------------------------------------------------
7 SOLE VOTING POWER
-0-
----------------------------------------------------------
NUMBER OF 8 SHARED VOTING POWER
SHARES
BENEFICIALLY 78,338
OWNED BY ----------------------------------------------------------
EACH 9 SOLE DISPOSITIVE POWER
REPORTING
PERSON WITH -0-
----------------------------------------------------------
10 SHARED DISPOSITIVE POWER
78,338
--------------------------------------------------------------------------------
11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH PERSON
78,338
--------------------------------------------------------------------------------
12 CHECK IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES
CERTAIN SHARES*
[ ]
--------------------------------------------------------------------------------
13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
0.2% (2)
--------------------------------------------------------------------------------
14 TYPE OF REPORTING PERSON*
PN
--------------------------------------------------------------------------------
* SEE INSTRUCTIONS
(2) See footnote (1) above.
------------------------------ ---------------------
CUSIP NO. 543162101 SCHEDULE 13D PAGE 4 OF 13 PAGES
------------------------------ ---------------------
--------------------------------------------------------------------------------
1 NAME OF REPORTING PERSON
ADVISORY RESEARCH SMALL MID CAP VALUE EQUITY FUND, L.P.
--------------------------------------------------------------------------------
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (a) [X]
(b) [ ]
--------------------------------------------------------------------------------
3 SEC USE ONLY
--------------------------------------------------------------------------------
4 SOURCE OF FUNDS*
OO
--------------------------------------------------------------------------------
5 CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT
TO ITEMS 2(d) or 2(e) [ ]
--------------------------------------------------------------------------------
6 CITIZENSHIP OR PLACE OF ORGANIZATION
ILLINOIS
--------------------------------------------------------------------------------
7 SOLE VOTING POWER
-0-
----------------------------------------------------------
NUMBER OF 8 SHARED VOTING POWER
SHARES
BENEFICIALLY 59,300
OWNED BY ----------------------------------------------------------
EACH 9 SOLE DISPOSITIVE POWER
REPORTING
PERSON WITH -0-
----------------------------------------------------------
10 SHARED DISPOSITIVE POWER
59,300
--------------------------------------------------------------------------------
11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH PERSON
59,300
--------------------------------------------------------------------------------
12 CHECK IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES
CERTAIN SHARES*
[ ]
--------------------------------------------------------------------------------
13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
0.2% (3)
--------------------------------------------------------------------------------
14 TYPE OF REPORTING PERSON*
PN
--------------------------------------------------------------------------------
* SEE INSTRUCTIONS
(3) See footnote (1) above.
------------------------------ ---------------------
CUSIP NO. 543162101 SCHEDULE 13D PAGE 5 OF 13 PAGES
------------------------------ ---------------------
--------------------------------------------------------------------------------
1 NAME OF REPORTING PERSON
ADVISORY RESEARCH SMALL CAP EQUITY FUND II, L.P.
--------------------------------------------------------------------------------
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (a) [X]
(b) [ ]
--------------------------------------------------------------------------------
3 SEC USE ONLY
--------------------------------------------------------------------------------
4 SOURCE OF FUNDS*
OO
--------------------------------------------------------------------------------
5 CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT
TO ITEMS 2(d) or 2(e) [ ]
--------------------------------------------------------------------------------
6 CITIZENSHIP OR PLACE OF ORGANIZATION
ILLINOIS
--------------------------------------------------------------------------------
7 SOLE VOTING POWER
-0-
----------------------------------------------------------
NUMBER OF 8 SHARED VOTING POWER
SHARES
BENEFICIALLY 62,690
OWNED BY ----------------------------------------------------------
EACH 9 SOLE DISPOSITIVE POWER
REPORTING
PERSON WITH -0-
----------------------------------------------------------
10 SHARED DISPOSITIVE POWER
62,690
--------------------------------------------------------------------------------
11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH PERSON
62,690
--------------------------------------------------------------------------------
12 CHECK IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES
CERTAIN SHARES*
[ ]
--------------------------------------------------------------------------------
13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
0.2% (4)
--------------------------------------------------------------------------------
14 TYPE OF REPORTING PERSON*
PN
--------------------------------------------------------------------------------
* SEE INSTRUCTIONS
(4) See footnote (1) above.
------------------------------ ---------------------
CUSIP NO. 543162101 SCHEDULE 13D PAGE 6 OF 13 PAGES
------------------------------ ---------------------
--------------------------------------------------------------------------------
1 NAME OF REPORTING PERSON
ADVISORY RESEARCH SMALL MID CAP VALUE EQUITY FUND II, L.P.
--------------------------------------------------------------------------------
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (a) [X]
(b) [ ]
--------------------------------------------------------------------------------
3 SEC USE ONLY
--------------------------------------------------------------------------------
4 SOURCE OF FUNDS*
OO
--------------------------------------------------------------------------------
5 CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT
TO ITEMS 2(d) or 2(e) [ ]
--------------------------------------------------------------------------------
6 CITIZENSHIP OR PLACE OF ORGANIZATION
ILLINOIS
--------------------------------------------------------------------------------
7 SOLE VOTING POWER
-0-
----------------------------------------------------------
NUMBER OF 8 SHARED VOTING POWER
SHARES
BENEFICIALLY 130,030
OWNED BY ----------------------------------------------------------
EACH 9 SOLE DISPOSITIVE POWER
REPORTING
PERSON WITH -0-
----------------------------------------------------------
10 SHARED DISPOSITIVE POWER
130,030
--------------------------------------------------------------------------------
11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH PERSON
130,030
--------------------------------------------------------------------------------
12 CHECK IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES
CERTAIN SHARES*
[ ]
--------------------------------------------------------------------------------
13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
0.4% (5)
--------------------------------------------------------------------------------
14 TYPE OF REPORTING PERSON*
PN
--------------------------------------------------------------------------------
* SEE INSTRUCTIONS
(5) See footnote (1) above.
------------------------------ ---------------------
CUSIP NO. 543162101 SCHEDULE 13D PAGE 7 OF 13 PAGES
------------------------------ ---------------------
--------------------------------------------------------------------------------
1 NAME OF REPORTING PERSON
ADVISORY RESEARCH ALL CAP FUND, L.P.
--------------------------------------------------------------------------------
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (a) [X]
(b) [ ]
--------------------------------------------------------------------------------
3 SEC USE ONLY
--------------------------------------------------------------------------------
4 SOURCE OF FUNDS*
OO
--------------------------------------------------------------------------------
5 CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT
TO ITEMS 2(d) or 2(e) [ ]
--------------------------------------------------------------------------------
6 CITIZENSHIP OR PLACE OF ORGANIZATION
ILLINOIS
--------------------------------------------------------------------------------
7 SOLE VOTING POWER
-0-
----------------------------------------------------------
NUMBER OF 8 SHARED VOTING POWER
SHARES
BENEFICIALLY 8,650
OWNED BY ----------------------------------------------------------
EACH 9 SOLE DISPOSITIVE POWER
REPORTING
PERSON WITH -0-
----------------------------------------------------------
10 SHARED DISPOSITIVE POWER
8,650
--------------------------------------------------------------------------------
11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH PERSON
8,650
--------------------------------------------------------------------------------
12 CHECK IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES
CERTAIN SHARES*
[ ]
--------------------------------------------------------------------------------
13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
0.02% (6)
--------------------------------------------------------------------------------
14 TYPE OF REPORTING PERSON*
PN
--------------------------------------------------------------------------------
* SEE INSTRUCTIONS
(6) See footnote (1) above.
------------------------------ ---------------------
CUSIP NO. 543162101 SCHEDULE 13D PAGE 8 OF 13 PAGES
------------------------------ ---------------------
--------------------------------------------------------------------------------
1 NAME OF REPORTING PERSON
ADVISORY RESEARCH GLOBAL ALL CAP FUND, L.P.
--------------------------------------------------------------------------------
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (a) [X]
(b) [ ]
--------------------------------------------------------------------------------
3 SEC USE ONLY
--------------------------------------------------------------------------------
4 SOURCE OF FUNDS*
OO
--------------------------------------------------------------------------------
5 CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT
TO ITEMS 2(d) or 2(e) [ ]
--------------------------------------------------------------------------------
6 CITIZENSHIP OR PLACE OF ORGANIZATION
ILLINOIS
--------------------------------------------------------------------------------
7 SOLE VOTING POWER
-0-
----------------------------------------------------------
NUMBER OF 8 SHARED VOTING POWER
SHARES
BENEFICIALLY 662
OWNED BY ----------------------------------------------------------
EACH 9 SOLE DISPOSITIVE POWER
REPORTING
PERSON WITH -0-
----------------------------------------------------------
10 SHARED DISPOSITIVE POWER
662
--------------------------------------------------------------------------------
11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH PERSON
662
--------------------------------------------------------------------------------
12 CHECK IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES
CERTAIN SHARES*
[ ]
--------------------------------------------------------------------------------
13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
Less than 0.01% (7)
--------------------------------------------------------------------------------
14 TYPE OF REPORTING PERSON*
PN
--------------------------------------------------------------------------------
* SEE INSTRUCTIONS
(7) See footnote (1) above.
------------------------------ ---------------------
CUSIP NO. 543162101 SCHEDULE 13D PAGE 9 OF 13 PAGES
------------------------------ ---------------------
ITEM 1. SECURITY AND ISSUER
The Schedule 13D filed on August 20, 2008, amended on September 12,
2008 and again on October 1,2008 by Advisory Research, Inc. ("ARI"), a
Delaware corporation, Advisory Research Small Cap Equity Fund, L.P.
("Advisory Small Cap"), Advisory Research Small Mid Cap Value Equity Fund,
L.P. ("Advisory Small Mid Cap"), Advisory Research Small Cap Equity Fund II,
L.P. ("Advisory Small Cap II"), Advisory Research Small Mid Cap Value Equity
Fund II, L.P. ("Advisory Small Mid Cap II"), Advisory Research All Cap Fund,
L.P. ("Advisory All Cap"), and Advisory Research Global All Cap Fund, L.P.
("Advisory Global All Cap") and along with ARI, the "Reporting Persons", with
respect to the common stock, par value $0.50 per share (the "Common Stock")
of Longs Drug Stores Corp. (the "Company"), Maryland corporation, is hereby
amended by this Amendment No. 3. Only those items hereby reported in this
Amendment No. 3 are amended and all other items remain unchanged.
ITEM 3. SOURCE AND AMOUNT OF FUNDS OR OTHER CONSIDERATION.
Item 3. is hereby restated as follows:
Funds for the purchase of the Common Stock reported herein were
derived from available capital of the Advisory Small Cap, Advisory Small
Mid Cap, Advisory Small Cap II, Advisory Small Mid Cap II, Advisory All
Cap and Advisory Global All Cap funds as well as client funds of ARI.
A total of approximately $127.8 million was paid to acquire such Common
Stock.
ITEM 4. PURPOSE OF TRANSACTION.
Item 4 is hereby supplemented, as follows:
Reference is made to the Reporting Persons' press release, dated
October 10, 2008, a copy of which is attached hereto as Exhibit D and is
incorporated herein by reference.
------------------------------ ---------------------
CUSIP NO. 543162101 SCHEDULE 13D PAGE 10 OF 13 PAGES
------------------------------ ---------------------
ITEM 5. INTEREST IN SECURITIES OF THE ISSUER.
Paragraphs (a), (b) and (c) of Item 5 of the Schedule 13D are hereby
restated as follows:
(a) As of the close of business on October 9, 2008, ARI may be
deemed the beneficial owner of an aggregate of 3,295,893 shares of Common
Stock, constituting approximately 9.2% of the Common Stock outstanding.
Advisory Small Cap may be deemed the beneficial owner of 78,338 shares of
Common Stock, constituting approximately 0.2% of the Common Stock outstanding.
Advisory Small Mid Cap may be deemed the beneficial owner of 59,300 shares
of Common Stock, constituting approximately 0.2% of the Common Stock
outstanding. Advisory Small Cap II may be deemed the beneficial owner of
62,690 shares of Common Stock, constituting approximately 0.2% of the
Common Stock outstanding. Advisory Small Mid Cap II may be deemed the
beneficial owner of 130,030 shares of Common Stock, constituting
approximately 0.4% of the Common Stock outstanding. Advisory All Cap
may be deemed the beneficial owner of 8,650 shares of Common Stock,
constituting approximately 0.02% of the Common Stock outstanding.
Advisory Global All Cap may be deemed the beneficial owner of 662 shares
of Common Stock, constituting approximately 0.00% of the Common Stock
outstanding.
The aggregate percentage of shares of Common Stock beneficially
owned by the Reporting Persons is based upon 36,007,597 shares of Common
Stock outstanding, which is the total number of shares of Common Stock
outstanding as of August 14, 2008 as reported in the Company's Schedule
14D9 filed with the Securities and Exchange Commission on August 18, 2008.
(b) By virtue of investment management agreements with each of
Advisory Small Cap, Advisory Small Mid Cap, Advisory Small Cap II, Advisory
Small Mid Cap II, Advisory All Cap and Advisory Global All Cap, and other
discretionary client funds, ARI has the power to vote or direct the voting,
and to dispose or direct the disposition, of all of the 3,295,893 shares of
Common Stock held by ARI. Advisory Small Cap has the power to vote or direct
the voting, and to dispose or direct the disposition of all of the 78,338
shares of Common Stock it holds. Advisory Small Mid Cap has the power to
vote or direct the voting, and to dispose or direct the disposition of all
of the 59,300 shares of Common Stock it holds. Advisory Small Cap II has
the power to vote or direct the voting, and to dispose or direct the
disposition of all of the 62,690 shares of Common Stock it holds. Advisory
Small Mid Cap II has the power to vote or direct the voting, and to dispose
or direct the disposition of all of the 130,030 shares of Common Stock it
holds. Advisory All Cap has the power to vote or direct the voting, and
to dispose or direct the disposition of all of the 8,650 shares of Common
Stock it holds. Advisory Global All Cap has the power to vote or direct
the voting, and to dispose or direct the disposition of all of the 662
shares of Common Stock it holds. Accordingly, ARI is deemed to have shared
voting and shared dispositive power with respect to an aggregate of 3,295,893
shares of Common Stock.
(c) Information concerning transactions in the shares of Common Stock
effected by the Reporting Persons in since the most recent filing on Schedule
13D on October 1, 2008 is set forth in Schedule A hereto and is incorporated
herein by reference. Unless otherwise indicated, all of such transactions
were effected in the open market.
ITEM 6. CONTRACTS, ARRANGEMENTS, UNDERSTANDINGS OR RELATIONSHIPS WITH
RESPECT TO SECURITIES OF THE ISSUER.
Except for ARI acting as investment advisor for its clients who own the
shares of Common Stock described herein, the Reporting Persons do not have any
contract, arrangement, understanding or relationship with any person with
respect to the securities of the Company.
ITEM 7. MATERIAL TO BE FILED AS EXHIBITS
Exhibit D - Press Release dated October 10, 2008.
--------------------------- -------------------
CUSIP NO. 543162101 SCHEDULE 13D PAGE 11 OF 13 PAGES
--------------------------- -------------------
SIGNATURES
After reasonable inquiry and to the best of his or its knowledge and
belief, the undersigned certifies that the information set forth in this
statement is true, complete and correct.
Dated: October 10, 2008
ADVISORY RESEARCH, INC.
By: /s/ Brien M. O'Brien
---------------------------
Name: Brien M. O'Brien
Title: Chairman & CEO
ADVISORY RESEARCH SMALL CAP EQUITY FUND, L.P.
By: Advisory Research, Inc.,
General Partner
By: /s/ Brien M. O'Brien
---------------------------
Name: Brien M. O'Brien
Title: Chairman & CEO
ADVISORY RESEARCH SMALL MID CAP VALUE EQUITY
FUND, L.P.
By: Advisory Research, Inc.,
General Partner
By: /s/ Brien M. O'Brien
---------------------------
Name: Brien M. O'Brien
Title: Chairman & CEO
ADVISORY RESEARCH SMALL CAP EQUITY FUND II, L.P.
By: Advisory Research, Inc.,
General Partner
By: /s/ Brien M. O'Brien
---------------------------
Name: Brien M. O'Brien
Title: Chairman & CEO
ADVISORY RESEARCH SMALL MID CAP VALUE EQUITY
FUND II, L.P.
By: Advisory Research, Inc.,
General Partner
By: /s/ Brien M. O'Brien
---------------------------
Name: Brien M. O'Brien
Title: Chairman & CEO
ADVISORY RESEARCH ALL CAP FUND, L.P.
By: Advisory Research, Inc.,
General Partner
By: /s/ Brien M. O'Brien
---------------------------
Name: Brien M. O'Brien
Title: Chairman & CEO
ADVISORY RESEARCH GLOBAL ALL CAP FUND, L.P.
By: Advisory Research, Inc.,
General Partner
By: /s/ Brien M. O'Brien
---------------------------
Name: Brien M. O'Brien
Title: Chairman & CEO
--------------------------- -------------------
CUSIP NO. 543162101 SCHEDULE 13D PAGE 12 OF 13 PAGES
--------------------------- -------------------
EXHIBIT D
Advisory Research, Inc. to Tender all Clients'
Longs Stock into CVS Caremark Tender Offer
PRESS RELEASE
CONTACT: David Heller, President
Advisory Research, Inc.
180 N. Stetson - Suite 5500
Chicago, IL 60601
312-565-1414
CHICAGO, IL - Advisory Research, Inc. today announced that in view of
Walgreens' withdrawal of its Offer to Purchase all of the outstanding shares of
Longs Drug Stores Corporation (NYSE:LDG) and the turmoil in the markets,
Advisory Research, Inc. has determined to tender into the CVS Caremark
(NYSE:CVS) Tender Offer all of its clients' holdings of Longs representing
approximately 9.2% of the outstanding Longs' shares.
--------------------------- -------------------
CUSIP NO. 543162101 SCHEDULE 13D PAGE 13 OF 13 PAGES
--------------------------- -------------------
SCHEDULE A
Transactions in the shares by the Reporting Persons since October 1, 2008.
All of such transactions were effected in the open market. ARI effected its
transactions in its capacity as an investment manager on behalf of certain
managed accounts.
ADVISORY RESEARCH, INC.
Trade Date Shared Purchased (Sold) Price Per Share ($)
----------- ------------------------ -------------------
10/1/2008 (100) $75.82
10/2/2008 (450) $74.69
10/2/2008 (500) $74.50
10/3/2008 (890) $74.17
10/6/2008 (200) $72.62
10/6/2008 (100) $72.31
10/6/2008 (250) $72.32
10/6/2008 (200) $72.34
10/6/2008 (300) $72.35
10/6/2008 (360) $72.73
10/6/2008 (140) $72.99
10/8/2008 (1000) $71.74
10/10/2008 (70) $71.05
ADVISORY RESEARCH SMALL CAP
Trade Date Shared Purchased (Sold) Price Per Share ($)
----------- ------------------------ -------------------
NONE
ADVISORY RESEARCH SMALL MID CAP
Trade Date Shared Purchased (Sold) Price Per Share ($)
----------- ------------------------ -------------------
NONE
ADVISORY RESEARCH SMALL CAP II
Trade Date Shared Purchased (Sold) Price Per Share ($)
----------- ------------------------ -------------------
NONE
ADVISORY RESEARCH SMALL MID CAP II
Trade Date Shared Purchased (Sold) Price Per Share ($)
----------- ------------------------ -------------------
NONE
ADVISORY RESEARCH ALL CAP
Trade Date Shared Purchased (Sold) Price Per Share ($)
----------- ------------------------ -------------------
NONE
ADVISORY RESEARCH GLOBAL ALL CAP
Trade Date Shared Purchased (Sold) Price Per Share ($)
----------- ------------------------ -------------------
NONE
|
